Literature DB >> 3228003

Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.

B Grøgaard1, B Gerdin, K E Arfors.   

Abstract

Local cerebral blood flow (lCBF) was measured autoradiographically 60 min after 15 min of forebrain ischaemia in rats treated with flunarizine (0.1 mg/kg b.w.), lidoflazine (1.0 mg/kg b.w.) or Mg2+ (600 mumol/kg b.w.) before or at the end of the ischaemic period. Incomplete forebrain ischaemia was produced by a combination of common carotid artery occlusion and bleeding to a mean arterial blood pressure of 50 mmHg. During ischaemia lCBFs in cortical areas were less than 1% of preischaemic values. Neither flunarizine, lidoflazine nor Mg2+ influenced lCBF during ischaemia. Sixty minutes after the start of recirculation lCBFs were decreased to between 40 and 60% of the values found in control animals. None of the instituted treatments improved postischaemic cerebral blood flow. The results do not lend support to the view that calcium plays an essential role in the pathogenesis of delayed postischaemic hypoperfusion in the brain in this model.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3228003     DOI: 10.1007/bf01790775

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  30 in total

1.  Experimental evaluation of potential spasmolytic drugs.

Authors:  J Kapp; M S Mahaley; G L Odom
Journal:  J Neurosurg       Date:  1970-04       Impact factor: 5.115

2.  Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs.

Authors:  C P Winegar; O Henderson; B C White; R E Jackson; T O'Hara; G S Krause; D N Vigor; R Kontry; W Wilson; C Shelby-Lane
Journal:  Ann Emerg Med       Date:  1983-08       Impact factor: 5.721

3.  Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle.

Authors:  P D Turlapaty; B M Altura
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

4.  Influence of magnesium on calcium- and potassium-related responses in vascular smooth muscle.

Authors:  O Carrier; R K Hester; H A Jurevics; T E Tenner
Journal:  Blood Vessels       Date:  1976

5.  Failure of flunarizine to improve cerebral blood flow or neurologic recovery in a canine model of complete cerebral ischemia.

Authors:  L A Newberg; P A Steen; J H Milde; J D Michenfelder
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

6.  Effect of flunarizine on canine cerebral cortical blood flow and vascular resistance post cardiac arrest.

Authors:  B C White; D S Gadzinski; P J Hoehner; C Krome; T Hoehner; J D White; J H Trombley
Journal:  Ann Emerg Med       Date:  1982-03       Impact factor: 5.721

7.  Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog.

Authors:  P A Steen; L A Newberg; J H Milde; J D Michenfelder
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

8.  Cerebral circulatory responses to hypercapnia and hypoxia in the recovery period following complete and incomplete cerebral ischemia in the rat.

Authors:  E Kågström; M L Smith; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1983-07

9.  Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: barbiturates, calcium antagonists, and magnesium.

Authors:  B M Altura; B T Altura
Journal:  Am J Emerg Med       Date:  1983-09       Impact factor: 2.469

10.  The effect of magnesium on the response of smooth muscle to 5-hydroxytryptamine.

Authors:  S Goldstein; T T Zsotér
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

View more
  1 in total

1.  Expressional changes in cerebrovascular receptors after experimental transient forebrain ischemia.

Authors:  Sara Johansson; Gro Klitgaard Povlsen; Lars Edvinsson
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.